Travel-acquired Japanese encephalitis and vaccination considerations

Authors

  • Androula Pavli Hellenic Center for Disease Control and Prevention, Athens, Greece
  • Helena C Maltezou Hellenic Center for Disease Control and Prevention, Athens, Greece

DOI:

https://doi.org/10.3855/jidc.5108

Keywords:

Japanese-encephalitis, vaccination, travelers

Abstract

Japanese encephalitis (JE) is a serious arboviral disease caused by a virus of the genus Flavivirus. Japanese encephalitis is the most common vaccine-preventable virus causing encephalitis in Asia, affecting more than 50,000 persons and leading to 15,000 fatalities per year in endemic countries. For most travelers to Asia, the risk of Japanese encephalitis infection is extremely low and depends on destination, duration of travel, season, and activities. This article reviews travel-acquired Japanese encephalitis with a focus on epidemiology and prevention in the light of the newly available options for active immunization against Japanese encephalitis which have become available, and of the increasing popularity of travels to Japanese encephalitis endemic countries.

Downloads

Published

2015-09-27

How to Cite

1.
Pavli A, Maltezou HC (2015) Travel-acquired Japanese encephalitis and vaccination considerations. J Infect Dev Ctries 9:917–924. doi: 10.3855/jidc.5108

Issue

Section

Reviews